癌症研究
癌症
恶性肿瘤
子宫内膜癌
成纤维细胞生长因子受体
生物
成纤维细胞生长因子受体1
乳腺癌
内科学
医学
成纤维细胞生长因子
肿瘤科
受体
作者
Teresa Helsten,Sheryl K. Elkin,Elisa Arthur,Brett N. Tomson,Jennifer Carter,Razelle Kurzrock
标识
DOI:10.1158/1078-0432.ccr-14-3212
摘要
FGFR aberrations are common in a wide variety of cancers, with the majority being gene amplifications or activating mutations. These data suggest that FGFR inhibition could be an important therapeutic option across multiple tumor types.
科研通智能强力驱动
Strongly Powered by AbleSci AI